Abstract
Objectives Promoting regular physical activity (PA) is essential in cardiac rehabilitation; yet many patients exhibit low levels of PA. In January 2022, the Improving Physical Activity (IMPACT) trial, a randomised controlled trial at the University Hospital of Geneva, was launched to promote PA in cardiac patients by targeting automatic approach tendencies towards exercise-related stimuli through a cognitive bias modification (CBM) intervention. This article examines the limited acceptance of this intervention, identifies potential barriers, and proposes strategies to improve future implementations.
Design Retrospective acceptance evaluation of a pre-registered clinical trial.
Setting The intervention was conducted in a cardiac rehabilitation centre in Switzerland.
Participants Sixty-eight cardiac rehabilitation patients (Mage = 57.76 ±□10.76 years, 87% male).
Intervention Patients received 12 CBM sessions over 6 weeks, designed to target approach-avoidance tendencies to exercise-related stimuli and improve PA levels.
Primary and secondary outcome measures Acceptance was assessed using behavioural (e.g., enrolment and engagement rates), cognitive (e.g., perceived effectiveness), and emotional (e.g., affective evaluation) indicators.
Results Of the 352 patients initially required, only 68 (19%) were enrolled. Among these 68, 17% completed the minimum number of CBM sessions, and 7% completed accelerometer-based PA measures during the week following discharge. These behavioural indicators of low acceptance were complemented by patients’ verbal reports, which showed cognitive (e.g., scepticism about the task relevance and perceived effectiveness of the intervention) and emotional (e.g., feelings of boredom and disinterest) barriers.
Conclusion The IMPACT trial’s inability to recruit and retain sufficient participants hindered the evaluation of its effectiveness in promoting PA among cardiac patients. These challenges highlight the importance of addressing patients’ perceptions of the task’s relevance and the satisfaction derived from it in order to improve intervention acceptance. Recommendations for improving behavioural, cognitive, and emotional acceptance are discussed, with the aim of increasing the effectiveness of rehabilitation programmes.
Strengths and limitations of this study
Developing innovative intervention to promote PA in cardiac rehabilitation is essential.
The intervention involved a computerised intervention targeting automatic precursors of PA behaviours
Low enrolment and engagement rates limit the ability to assess the effectiveness of the intervention.
The study identifies key barriers to acceptance, including cognitive (e.g., scepticism) and emotional (e.g., lack of motivation) factors, which hinder engagement.
The retrospective, unplanned, and unsystematic nature of the measures may introduce recall bias, reducing the validity and accuracy of the reported indicators.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://doi.org/10.1136/bmjopen-2021-053845
Funding Statement
L.F. is funded by the French Ministry of Higher Education, Research and Innovation. B.C. is supported by an Ambizione grant (PZ00P1_180040) from the Swiss National Science Foundation (SNSF).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of Commission cantonale d'éthique de la recherche CCER gave ethical approval for this work (reference number: CCER2019-02257)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.